|
FI942957A
|
|
Process for the preparation of peptides with T-cell helper activity
|
|
US5472856A
|
|
Recombinant human thymopoietin proteins and uses therefor
|
|
US5639729A
|
|
Tripeptides useful in immune and CNS therapy
|
|
IL104293D0
|
|
Pentapeptides having t cell helper activity
|
|
US5215964A
|
|
Peptides useful in regulating the immune and nervous systems
|
|
FI912461A0
|
|
Stabilizerade vattenhaltiga formulationer av smao peptider.
|
|
IL95663D0
|
|
Stabilized aqueous formulations of small peptides
|
|
RU2036930C1
|
|
Peptides and composition on their base capable to regulate immune function in mammalian
|
|
CA2028848A1
|
|
Lyophilized peptide formulations
|
|
IE900102L
|
|
Treatment of skin disorders
|
|
IL93030D0
|
|
Composition containing thymo-pentin for topical treatment of skin disorders
|
|
US5036050A
|
|
Compositions containing thymopentin for topical treatment of skin disorders
|
|
HU896052D0
|
|
Process for producing peptides having t cell suppressor activity and pharmaceutical compositions comprising same
|
|
DD284029A5
|
|
Peptides with t-cell support activities
|
|
IE891528L
|
|
Peptides
|
|
ZA8903414B
|
|
Probursin
|
|
IL104293A
|
|
Pentapeptides having t cell helper activity and pharmaceutical compositions containing them
|
|
NZ241224A
|
|
Pentapeptides having t cell helper activity
|
|
NZ229004A
|
|
Tetrapeptides having t cell helper acitivity
|
|
WO8909229A1
|
|
Treatment of hiv viremic patients with thymopentin
|
